Active substance
Dicycloverine
- US FDA 48
- Health Canada 3
- US price lines 3
- NHS prices 3
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| DICYCLOMINE HYDROCHLORIDE | 10MG | capsule · oral | LANNETT | Prescription | 30 Sep 1974 |
| DICYCLOMINE HYDROCHLORIDE | 10MG | capsule · oral | WATSON LABS | Prescription | 28 Jul 1976 |
| DICYCLOMINE HYDROCHLORIDE | 20MG | tablet · oral | WATSON LABS | Prescription | 17 Aug 1976 |
| DICYCLOMINE HYDROCHLORIDE | 20MG | tablet · oral | HIKMA PHARMS | Prescription | 1 Oct 1996 |
| DICYCLOMINE HYDROCHLORIDE | 10MG | capsule · oral | WEST WARD | Prescription | 28 Feb 1997 |
| DICYCLOMINE HYDROCHLORIDE | 20MG | tablet · oral | LANNETT | Prescription | 26 Feb 1999 |
| DICYCLOMINE HYDROCHLORIDE | 20MG | tablet · oral | AUROBINDO PHARMA USA | Prescription | 7 Sep 1999 |
| DICYCLOMINE HYDROCHLORIDE | 10MG | capsule · oral | AUROBINDO PHARMA USA | Prescription | 7 Sep 1999 |
| DICYCLOMINE HYDROCHLORIDE (PRESERVATIVE FREE) | 10MG/ML | injectable · injection | HIKMA PHARMS | Prescription | 30 Jun 2003 |
| DICYCLOMINE HYDROCHLORIDE | 10MG/5ML | syrup · oral | PH HEALTH | Prescription | 24 Mar 2005 |
| DICYCLOMINE HYDROCHLORIDE | 10MG/ML | injectable · injection | AM REGENT | Prescription | 17 Feb 2017 |
| DICYCLOMINE HYDROCHLORIDE | 10MG/ML | injectable · injection | FOSUN PHARMA | Prescription | 2 Jul 2018 |
| DICYCLOMINE HYDROCHLORIDE | 10MG/ML | injectable · injection | SLATE RUN PHARMA | Prescription | 2 Nov 2018 |
| DICYCLOMINE HYDROCHLORIDE | 10MG/ML | injectable · injection | FRESENIUS KABI USA | Prescription | 25 Jan 2019 |
| DICYCLOMINE HYDROCHLORIDE | 10MG/5ML | syrup · oral | HIKMA PHARMS | Prescription | 22 May 2020 |
| DICYCLOMINE HYDROCHLORIDE | 10MG/5ML | syrup · oral | NOVITIUM PHARMA | Prescription | 23 Apr 2021 |
| DICYCLOMINE HYDROCHLORIDE | 20MG | tablet · oral | COREPHARMA | Prescription | 28 Nov 2022 |
| DICYCLOMINE HYDROCHLORIDE | 20MG; 40MG | tablet · oral | RUBICON RESEARCH | Prescription | 14 Dec 2022 |
| DICYCLOMINE HYDROCHLORIDE | 10MG | capsule · oral | TWI PHARMS | Prescription | 27 Dec 2022 |
| DICYCLOMINE HYDROCHLORIDE | 10MG | capsule · oral | COREPHARMA | Prescription | 24 Mar 2023 |
| DICYCLOMINE HYDROCHLORIDE | 20MG | tablet · oral | TWI PHARMS | Prescription | 1 Jun 2023 |
| DICYCLOMINE HYDROCHLORIDE | 20MG | tablet · oral | BIONPHARMA | Prescription | 4 Aug 2023 |
| DICYCLOMINE HYDROCHLORIDE | 10MG | capsule · oral | PRINSTON INC | Prescription | 30 Aug 2023 |
| DICYCLOMINE HYDROCHLORIDE | 20MG | tablet · oral | ANNORA PHARMA | Prescription | 7 May 2024 |
| DICYCLOMINE HYDROCHLORIDE | 10MG | capsule · oral | ANNORA PHARMA | Prescription | 1 Jul 2024 |
23 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| JAMP-DICYCLOMINE HCL | 02366088 | 20 MG | TABLET · ORAL | JAMP PHARMA CORPORATION |
| JAMP-DICYCLOMINE HCL | 02391619 | 10 MG | TABLET · ORAL | JAMP PHARMA CORPORATION |
| RIVA-DICYCLOMINE | 00557102 | 10 MG | CAPSULE · ORAL | LABORATOIRE RIVA INC. |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | DICYCLOMINE 10 MG CAPSULE | $0.07775 | per EA | 23 Sep 2026 |
| US NADAC | DICYCLOMINE 10 MG/5 ML SOLN | $0.17356 | per ML | 23 Sep 2026 |
| US NADAC | DICYCLOMINE 20 MG TABLET | $0.059 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Dicycloverine 10mg tablets | £8.93 | 100 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Dicycloverine 10mg/5ml oral solution | £174.11 | 120 ml | 1 Oct 2026 |
| NHS Drug Tariff | Dicycloverine 20mg tablets | £9.28 | 84 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.